IP Library Granted Patent US 10,669,292
Granted Patent B2
US 10,669,292 · App. 16/530,625 · Granted Jun 2, 2020

Synthesis of boronate salts and uses thereof

Inventors: Scott Hecker (Del Mar, CA); Serge Boyer (San Diego, CA)
Assignee: REMPEX PHARMACEUTICALS, INC.
C07F5/025A01N55/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,669,292
App. No.
16/530,625
Granted
Jun 2, 2020
Kind
B2
Abstract

Disclosed herein are boronate intermediates in the synthesis of antimicrobial compounds and the use and preparation thereof. Some embodiments relate to crystalline boronate salt derivatives and their use in the synthesis of therapeutic compounds.

Claims (70)

1. A method of making a compound of Formula (I-F), or a salt thereof, comprising the steps of:

(a) decomplexing and protecting of a compound of Formula (I):

to form a compound of Formula (I-B):

(b) protecting a compound of Formula (I-B) to form a compound of Formula (I-C):

(c) halomethylating a compound of Formula (I-C) to form a compound of Formula (I-D):

(d) aminating a compound of Formula (I-D) and reacting with a compound of formula:

to form a compound of Formula (I-E):

(e) deprotecting a compound of Formula (I-E) to form a compound of Formula (I-F):

wherein the deprotection comprises de-esterification and de-complexation;

wherein:

PG is a hydroxyl protecting group;

n is 0 or 1;

Y 1 is O or N + R 5 R 6

Y 2 is O or NR 10 ;

R 1 and R 2 are independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl;

or R 1 and R 2 , together with the atoms to which they are attached, form ═O;

R 3 is selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl;

or R 1 and R 3 , together with the atoms to which they are attached, form a carbocyclic ring;

or R 3 and R 5 , together with the atoms to which they are attached, form a heteroaryl ring;

or R 3 and R 4 , together with the atoms to which they are attached, form ═O;

R 4 , R 5 , R 6 , and R 10 are each independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl;

R 9 is selected from the group consisting of optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl;

R 13 is selected from the group consisting of C 1-9 alkyl and C 1-9 alkyl-R 14 ; and

R 14 is selected from the group consisting of optionally substituted aryl, optionally substituted heteroaryl, optionally substituted carbocyclyl, and optionally substituted heterocyclyl.

2. The method of claim 1 , wherein for the compound of Formula (I):

n is 1;

Y 1 is O or N + R 5 R 6

Y 2 is O;

R 1 and R 2 are independently H;

or R 1 and R 2 , together with the atoms to which they are attached, form ═O;

R 3 and R 4 are independently H;

or R 3 and R 4 , together with the atoms to which they are attached, form ═O;

R 5 and R 6 are each independently H; and

R 9 is optionally substituted C 1 -C 12 alkyl.

3. The method of claim 1 , wherein the compound of Formula (I) is selected from the group consisting of:

wherein M + is a cation selected from the group consisting of lithium, sodium, potassium, calcium, ammonium, triethylammonium, and aluminum.

4. The method of claim 2 , wherein the compound of Formula (I) is:

5. The method of claim 1 , wherein:

PG is a trialkylsilyl group; and/or

R 13 is C 1-9 alkyl-R 14 ; and/or

R 14 is optionally substituted heteroaryl, optionally thiophene-2-yl.

6. The method of claim 1 , wherein the compound of Formula (I-F) is

7. The method of claim 1 , wherein, in step (a), the decomplexing and protecting the compound of Formula (I) takes place concomitantly or in separate individual steps.

8. The method of claim 1 , wherein step (a) comprises reacting the compound of Formula (I) with a boronate protecting group compound of Formula (G):

to form the compound of Formula (I-B);

wherein, for the compound of Formula (G):

n is 0 or 1;

R 1 , R 2 , R 3 , and R 4 are independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl;

or R 1 and R 3 together with the atoms to which they are attached form a carbocyclic ring.

9. The method of claim 8 , wherein, in step (a), the decomplexing and protecting a compound of Formula (I) takes place concomitantly by mixing the compound of Formula (I) with a boronate protecting group compound of Formula (G).

10. The method of claim 8 , wherein the boronate-protecting group compound of Formula (G) is selected from the group consisting of pinanediol, pinacol, 1,2-diisopropylethanediol, 1,2-diphenylethanediol, (+) pinanediol, and (−)-pinanediol.

11. The method of claim 1 , wherein step (c) comprises treating the compound of Formula (I-C) with n-butyllithium and dichloromethane, lithium diisopropylamide and dibromomethane, or lithium hexamethyldisilazide and dibromomethane.

12. The method of claim 1 , wherein step (d) comprises treating the compound of Formula (I-D) with an amine nucleophile and reacting with the compound:

under amide coupling conditions to form the compound of Formula (I-E).

13. The method of claim 1 , wherein de-esterification and de-complexation of the compound of Formula (I-E) are accomplished in more than one step.

14. The method of claim 1 , wherein de-esterification and de-complexation of the compound of Formula (I-E) are accomplished in one step.

15. The method of claim 14 , wherein de-esterification and de-complexation of the compound of Formula (I-E) is accomplished by treatment with aqueous acid, dioxane and boronic acid.

16. The method of claim 1 , comprising the steps of:

(a) decomplexing and protecting a compound 10:

with pinanediol to form a compound 11:

(b) protecting a compound 11 to form a compound 12:

(c) halomethylating a compound 12 to form a compound 13:

(d) aminating a compound 13 and reacting with a compound of formula:

to form a compound 14:

(e) deprotecting a compound 14 to form a compound 15:

wherein the deprotection comprises de-esterification and de-complexation.

17. The method of claim 9 , wherein the mixing is in a biphasic solvent system and wherein the biphasic solvent system comprises water and one or more solvent selected from the group consisting of MTBE, CH 2 Cl 2 , ethyl acetate, 2-Me-THF, CPME, and diisopropyl ether.

18. The method of claim 10 , wherein the boronate-protecting group compound of Formula (G) is (+)-pinanediol or (−)-pinanediol.

19. The method of claim 12 , wherein the amine nucleophile is selected from the group consisting of lithium hexamethyldisilazide and ammonia.

20. The method of claim 15 , wherein the aqueous acid is sulfuric acid.

Assignments (6)
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 25, 2022
From: MELINTA SUBSIDIARY CORP.
To: SILICON VALLEY BANK
Reel/Frame 061314/0572 →
CHANGE OF NAME Recorded Dec 30, 2020
From: MELINTA THERAPEUTICS, INC.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 054778/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2020
From: REMPEX PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 054755/0846 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 22, 2020
From: REMPEX PHARMACEUTICALS, INC.
To: SILICON VALLEY BANK
Reel/Frame 054836/0739 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2019
From: HECKER, SCOTT; BOYER, SERGE
To: REMPEX PHARMACEUTICALS, INC.
Reel/Frame 050950/0679 →
SECURITY INTEREST Recorded Sep 19, 2019
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; MELINTA SUBSIDIARY CORP.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 050429/0811 →